Labor Market Discrimination and Substance Use Disorders
Labor Market Discrimination and Substance Use Disorders
批准号:
7501306
负责人:
Marjorie L. Baldwin
金额:
$8.02万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-28 至 2010-08-31
关键词:
AffectAgeAlcohol or Other Drugs useAlcoholsAmericanAreaArtsAttitudeCategoriesCharacteristicsCommunitiesConditionDataData SetDependenceDisabled PersonsDiscriminationDiseaseDrug userEconometric ModelsEconomicsEducationEducational BackgroundEmploymentEmployment OpportunitiesFrequenciesGrantHealthIncomeInterventionInvestigationLawsLiteratureMarketingMeasuresMental HealthMental disordersNational Institute of Drug AbuseNational Institute of Mental HealthOutcomePersonal SatisfactionPersonsPoliciesPopulationPopulation Attributable RisksProbabilityProductivityPublic HealthPublishingRateRecording of previous eventsRehabilitation therapyRelative (related person)ResearchSample SizeSamplingSampling StudiesSeriesStigmataSubgroupSubstance Use DisorderSupport of ResearchSurveysTechniquesTimeVariantWagesWorkWorkers&apos Compensationage groupdisabilitydrinkingexperiencehuman capitalimprovedinterestproductivity lossprogramssevere mental illnesssocial stigmasubstance abusersuccesstherapy designtool
中文摘要
描述(申请人提供):物质使用障碍在生产力和收入损失方面给美国经济带来了巨大的负担。有物质使用障碍的人比有其他健康状况的人更容易受到耻辱,这表明部分损失可能归因于雇主的歧视。我们的初步研究发现有证据表明,药物滥用/依赖史对就业率有显著的负面影响,但尚不清楚就业差异的哪一部分可归因于有和没有药物使用障碍病史的人与生产力相关的特征的差异,以及哪部分可潜在地归因于耻辱。还没有研究应用最先进的计量经济学技术来具体衡量耻辱与生产率相关因素在决定这一群体的就业结果方面的相对重要性。这项拟议的研究使用了1991-92年全国酒精纵向流行病学调查和2001-02年全国酒精及相关疾病流行病学调查的数据,对歧视对药物使用障碍患者就业结果的潜在影响进行了严格的经济分析。总体目标是利用最先进的计量经济学工具,分析这两个具有全国代表性的大型劳动适龄人口调查,以确定在《美国残疾人法》(ADA)实施之前和之后,患有前物质使用障碍的人的具体就业决定因素。研究样本仅限于有既往但不是当前药物使用障碍的人,以与ADA的覆盖范围一致。我们利用ADA之前对药物使用障碍患者的就业保护的州际差异来估计该法律对这一群体就业结果的可能影响。这项研究填补了文献中的一个重要空白,因为在实施十年后,仍然缺乏客观的实证信息,说明ADA在改善药物使用障碍者的就业机会方面的有效性。拟议的项目与公共卫生有关,因为其结果将为旨在改善既往药物使用障碍患者就业机会的政策干预措施提供信息。生产性就业已被证明是精神障碍患者康复、自我价值和总体福祉以及他们融入社区的重要组成部分。该项目使用最先进的计量经济学模型来估计歧视对既往药物使用障碍者就业结果的潜在影响,并分析1990年《美国残疾人法》在改善这一群体的就业机会方面的成效。例如,如果发现歧视具有潜在的重要性,适当的干预措施是有针对性的教育,以减少与药物使用史相关的耻辱。如果结果表明ADA没有发挥预期的效果,那么需要进一步调查,以确定为什么政策变化对这一群体无效。
英文摘要
DESCRIPTION (provided by applicant): Substance use disorders impose a tremendous burden on the U.S. economy in terms of lost productivity and income. Persons with substance use disorders are more stigmatized than persons with other health conditions, suggesting that part of the losses may be attributed to employer discrimination. Our preliminary research finds evidence that a history of substance abuse/dependence has a significant negative impact on employment rates, but it is unclear what part of the employment differential is attributed to differences in the productivity-related characteristics of those with and without a history of substance use disorders, and what part can potentially be attributed to stigma. No studies have applied state-of-the-art econometric techniques to measure specifically the relative importance of stigma vs. productivity-related factors in determining employment outcomes for this group. The proposed research uses data from the 1991-92 National Longitudinal Alcohol Epidemiologic Survey and the 2001-02 National Epidemiologic Survey on Alcohol and Related Conditions to conduct a rigorous economic analysis of the potential impact of discrimination on employment outcomes for persons with substance use disorders. The overall objective is to analyze these two large, nationally representative surveys of working-age persons, using state-of-the-art econometric tools, to identify specific determinants of employment for persons with former substance use disorders in periods before and after implementation of the Americans with Disabilities Act (ADA). Study samples are restricted to persons with former, but not current, substance use disorders to be consistent with coverage of the ADA. We exploit inter-state variations in employment protections for persons with substance use disorders prior to the ADA to estimate the likely impact of the law on employment outcomes for this group. The research fills an important gap in the literature because, ten years after implementation, objective empirical information on how effective the ADA has been in improving employment opportunities for persons with substance use disorders is still lacking. The proposed project is relevant to public health because the results will inform policy interventions designed to improve employment opportunities for persons with former substance use disorders. Productive employment has been shown to be an essential component to the rehabilitation, self-worth and general well being of persons with mental disorders, and to their integration into the community. The project uses state- of-the-art econometric models to estimate the potential impact of discrimination on employment outcomes for persons with former substance use disorders, and to analyze how effective the Americans with Disabilities Act of 1990 has been in improving employment opportunities for this population. If, for example, discrimination is found to be potentially important, an appropriate intervention is targeted education to reduce the stigma associated with a history of substance use. If the results suggest that the ADA has not had its intended effects, then further investigation is needed to identify why the policy change has been ineffective for this group.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Disclosure of Serious Mental Illness in the Workplace
-
批准号:9924662
-
项目类别:
-
资助金额:$46.94万
-
财政年份:2017
-
负责人:Marjorie L. Baldwin
-
依托单位:
Labor Market Discrimination and Substance Use Disorders
-
批准号:7257376
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2007
-
负责人:Marjorie L. Baldwin
-
依托单位:
Persons with Mental Disorders in the Labor Market
-
批准号:6706999
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2003
-
负责人:Marjorie L. Baldwin
-
依托单位:
Persons with Mental Disorders in the Labor Market
-
批准号:6561777
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2003
-
负责人:Marjorie L. Baldwin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: